Intensive neurofeedback for children with ADHD: personalized vs. standard theta-beta training

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a school-holiday camp setting, children with ADHD are randomly assigned to either standard theta-beta neurofeedback or an iAPF-based theta-beta neurofeedback, delivered across 16 sessions over eight days. EEG data and reports from parents, teachers, and the children will be used to evaluate changes in ADHD symptoms and related behaviors. The trial aims to determine feasibility, signal validity, and potential symptom reduction, guiding future larger studies. Participants are 6-13 years old, German-speaking, with ADHD diagnoses, and ongoing medication status is tracked as a control variable.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Children aged 6-13 years. Confirmed ADHD diagnosis (ICD 10: F90.0, F90.1, or F98.8)
* German-speaking children with normal or corrected vision.

Exclusion Criteria:

* Children with neurological disorders (e.g., Epilepsy)
* Children without an ADHD diagnosis
* Caregivers with inability to provide informed consent or complete questionnaires
* Participation in neurofeedback that was conducted in the year prior to the intended participation or is still ongoing.

The intake of medication or psychotherapeutic treatments and ICD-10 diagnosis are queried at T1, T2 and T3. These are recorded as control variables and are not exclusion criteria. The medication intake was kept constant during the NF training.

Where it's running

• Bielefeld University
  Bielefeld, Germany Recruiting
• Philipps-University Marburg
  Marburg, Germany Recruiting

Study contacts

• Principal investigator: Björn Albrecht, Dr. — Philipps University Marburg
• Study coordinator: Luisa Himmelmeier, M.Sc. Psychology
• Email: Lhimmelmeier@uni-bielefeld.de
• Phone: +49 (0) 521 106 67534

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers that predict medication-related side effects in children with ADHD

  This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07900451

• Group CBT vs. Activity Group for Adults with ADHD

  This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.

  Recruiting at 2 sites Region Stockholm · Stockholm and 1 other locations · NCT07834437

• Central Executive Training and Behavioral Parent Training for Young Children with ADHD

  This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.

  Recruiting Florida State University · Tallahassee, Florida · NCT07784348

• Solriamfetol for ADHD in teens: see if it helps with focus

  This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.

  Recruiting at 31 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 30 other locations · NCT07717892

• Solriamfetol for children with ADHD: a 6-week comparison to placebo

  This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.

  Recruiting at 32 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 31 other locations · NCT07717879

• Personalized E-Fit program to help executive skills in kids with complex congenital heart disease

  A tailored digital training program called E-Fit tests whether targeted brain-training, online coaching, and hands-on games can improve everyday executive skills in 9- to 13-year-olds who have complex congenital heart disease.

  Recruiting University Children's Hospital, Zurich · Zurich, Canton of Zurich · NCT07692958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.